Platelet Transfusion Improves Liver Function in Patients with Chronic Liver Disease and Cirrhosis
Chronic liver disease (CLD), such as hepatitis C, is a progressive disease consisting of the destruction and regeneration of the liver parenchyma, leading to fibrosis and cirrhosis. Platelets contain various growth factors and may play important roles in liver regeneration. Thus, to investigate whet...
Saved in:
| Published in | The Tohoku Journal of Experimental Medicine Vol. 229; no. 3; pp. 213 - 220 |
|---|---|
| Main Authors | , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Japan
Tohoku University Medical Press
01.03.2013
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0040-8727 1349-3329 1349-3329 |
| DOI | 10.1620/tjem.229.213 |
Cover
| Abstract | Chronic liver disease (CLD), such as hepatitis C, is a progressive disease consisting of the destruction and regeneration of the liver parenchyma, leading to fibrosis and cirrhosis. Platelets contain various growth factors and may play important roles in liver regeneration. Thus, to investigate whether platelet transfusion improves liver function in patients with CLD and cirrhosis, we conducted an exploratory clinical trial. The study included 10 patients with CLD and cirrhosis (Child-Pugh class A or B), who all presented thrombocytopenia (platelet counts between 50,000 and 100,000 /μl). The subjects received 10 units of platelet concentrate once a week for 12 weeks. They were followed up for 9 months after the last transfusion. One patient discontinued platelet transfusion because of pruritus, and 2 patients discontinued because of platelet transfusion refractoriness. One patient was excluded from the analysis for receiving a procedural treatment after 12 platelet transfusions. Thus, the remaining 6 patients were analyzed. The platelet count did not increase significantly after the last transfusion. Significant improvement of serum albumin was observed at 1 month and 3 months after the last transfusion. Serum cholinesterase improved significantly at 1 week, 3 months, and 9 months after the last transfusion. Serum hyaluronic acid showed a tendency toward improvement after the last transfusion. In conclusion, platelet transfusion improved some of the indicators of liver function in patients with CLD and cirrhosis, though adverse events related to platelet transfusion were observed in some patients. Platelet increment therapy could be a new strategy for treating CLD and cirrhosis. |
|---|---|
| AbstractList | Chronic liver disease (CLD), such as hepatitis C, is a progressive disease consisting of the destruction and regeneration of the liver parenchyma, leading to fibrosis and cirrhosis. Platelets contain various growth factors and may play important roles in liver regeneration. Thus, to investigate whether platelet transfusion improves liver function in patients with CLD and cirrhosis, we conducted an exploratory clinical trial. The study included 10 patients with CLD and cirrhosis (Child-Pugh class A or B), who all presented thrombocytopenia (platelet counts between 50,000 and 100,000 /µl). The subjects received 10 units of platelet concentrate once a week for 12 weeks. They were followed up for 9 months after the last transfusion. One patient discontinued platelet transfusion because of pruritus, and 2 patients discontinued because of platelet transfusion refractoriness. One patient was excluded from the analysis for receiving a procedural treatment after 12 platelet transfusions. Thus, the remaining 6 patients were analyzed. The platelet count did not increase significantly after the last transfusion. Significant improvement of serum albumin was observed at 1 month and 3 months after the last transfusion. Serum cholinesterase improved significantly at 1 week, 3 months, and 9 months after the last transfusion. Serum hyaluronic acid showed a tendency toward improvement after the last transfusion. In conclusion, platelet transfusion improved some of the indicators of liver function in patients with CLD and cirrhosis, though adverse events related to platelet transfusion were observed in some patients. Platelet increment therapy could be a new strategy for treating CLD and cirrhosis. Chronic liver disease (CLD), such as hepatitis C, is a progressive disease consisting of the destruction and regeneration of the liver parenchyma, leading to fibrosis and cirrhosis. Platelets contain various growth factors and may play important roles in liver regeneration. Thus, to investigate whether platelet transfusion improves liver function in patients with CLD and cirrhosis, we conducted an exploratory clinical trial. The study included 10 patients with CLD and cirrhosis (Child-Pugh class A or B), who all presented thrombocytopenia (platelet counts between 50,000 and 100,000 /µl). The subjects received 10 units of platelet concentrate once a week for 12 weeks. They were followed up for 9 months after the last transfusion. One patient discontinued platelet transfusion because of pruritus, and 2 patients discontinued because of platelet transfusion refractoriness. One patient was excluded from the analysis for receiving a procedural treatment after 12 platelet transfusions. Thus, the remaining 6 patients were analyzed. The platelet count did not increase significantly after the last transfusion. Significant improvement of serum albumin was observed at 1 month and 3 months after the last transfusion. Serum cholinesterase improved significantly at 1 week, 3 months, and 9 months after the last transfusion. Serum hyaluronic acid showed a tendency toward improvement after the last transfusion. In conclusion, platelet transfusion improved some of the indicators of liver function in patients with CLD and cirrhosis, though adverse events related to platelet transfusion were observed in some patients. Platelet increment therapy could be a new strategy for treating CLD and cirrhosis.Chronic liver disease (CLD), such as hepatitis C, is a progressive disease consisting of the destruction and regeneration of the liver parenchyma, leading to fibrosis and cirrhosis. Platelets contain various growth factors and may play important roles in liver regeneration. Thus, to investigate whether platelet transfusion improves liver function in patients with CLD and cirrhosis, we conducted an exploratory clinical trial. The study included 10 patients with CLD and cirrhosis (Child-Pugh class A or B), who all presented thrombocytopenia (platelet counts between 50,000 and 100,000 /µl). The subjects received 10 units of platelet concentrate once a week for 12 weeks. They were followed up for 9 months after the last transfusion. One patient discontinued platelet transfusion because of pruritus, and 2 patients discontinued because of platelet transfusion refractoriness. One patient was excluded from the analysis for receiving a procedural treatment after 12 platelet transfusions. Thus, the remaining 6 patients were analyzed. The platelet count did not increase significantly after the last transfusion. Significant improvement of serum albumin was observed at 1 month and 3 months after the last transfusion. Serum cholinesterase improved significantly at 1 week, 3 months, and 9 months after the last transfusion. Serum hyaluronic acid showed a tendency toward improvement after the last transfusion. In conclusion, platelet transfusion improved some of the indicators of liver function in patients with CLD and cirrhosis, though adverse events related to platelet transfusion were observed in some patients. Platelet increment therapy could be a new strategy for treating CLD and cirrhosis. Chronic liver disease (CLD), such as hepatitis C, is a progressive disease consisting of the destruction and regeneration of the liver parenchyma, leading to fibrosis and cirrhosis. Platelets contain various growth factors and may play important roles in liver regeneration. Thus, to investigate whether platelet transfusion improves liver function in patients with CLD and cirrhosis, we conducted an exploratory clinical trial. The study included 10 patients with CLD and cirrhosis (Child-Pugh class A or B), who all presented thrombocytopenia (platelet counts between 50,000 and 100,000 /μl). The subjects received 10 units of platelet concentrate once a week for 12 weeks. They were followed up for 9 months after the last transfusion. One patient discontinued platelet transfusion because of pruritus, and 2 patients discontinued because of platelet transfusion refractoriness. One patient was excluded from the analysis for receiving a procedural treatment after 12 platelet transfusions. Thus, the remaining 6 patients were analyzed. The platelet count did not increase significantly after the last transfusion. Significant improvement of serum albumin was observed at 1 month and 3 months after the last transfusion. Serum cholinesterase improved significantly at 1 week, 3 months, and 9 months after the last transfusion. Serum hyaluronic acid showed a tendency toward improvement after the last transfusion. In conclusion, platelet transfusion improved some of the indicators of liver function in patients with CLD and cirrhosis, though adverse events related to platelet transfusion were observed in some patients. Platelet increment therapy could be a new strategy for treating CLD and cirrhosis. |
| Author | Nozaki, Reiji Sasaki, Ryoko Murata, Soichiro Ohkohchi, Nobuhiro Maruyama, Takehito Tamura, Takafumi Takahashi, Kazuhiro Ikeda, Naoya Fukunaga, Kiyoshi Oda, Tatsuya |
| Author_xml | – sequence: 1 fullname: Fukunaga, Kiyoshi organization: Department of Surgery, Division of Gastroenterological and Hepatobiliary Surgery, and Organ Transplantation, University of Tsukuba – sequence: 1 fullname: Sasaki, Ryoko organization: Department of Surgery, Division of Gastroenterological and Hepatobiliary Surgery, and Organ Transplantation, University of Tsukuba – sequence: 1 fullname: Ikeda, Naoya organization: Department of Surgery, Division of Gastroenterological and Hepatobiliary Surgery, and Organ Transplantation, University of Tsukuba – sequence: 1 fullname: Tamura, Takafumi organization: Department of Surgery, Division of Gastroenterological and Hepatobiliary Surgery, and Organ Transplantation, University of Tsukuba – sequence: 1 fullname: Nozaki, Reiji organization: Department of Surgery, Division of Gastroenterological and Hepatobiliary Surgery, and Organ Transplantation, University of Tsukuba – sequence: 1 fullname: Takahashi, Kazuhiro organization: Department of Surgery, Division of Gastroenterological and Hepatobiliary Surgery, and Organ Transplantation, University of Tsukuba – sequence: 1 fullname: Ohkohchi, Nobuhiro organization: Department of Surgery, Division of Gastroenterological and Hepatobiliary Surgery, and Organ Transplantation, University of Tsukuba – sequence: 1 fullname: Murata, Soichiro organization: Department of Surgery, Teikyo University Chiba Medical Center – sequence: 1 fullname: Oda, Tatsuya organization: Department of Surgery, Division of Gastroenterological and Hepatobiliary Surgery, and Organ Transplantation, University of Tsukuba – sequence: 1 fullname: Maruyama, Takehito organization: Department of Surgery, Division of Gastroenterological and Hepatobiliary Surgery, and Organ Transplantation, University of Tsukuba |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23459612$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kEtrGzEURkVJaJy0u66Lll1kHElXnseuxXmCIVmka6GRrmqZGU0qaVL67zPGjgOBrC5893x6nFNyFIaAhHzjbM5LwS7yBvu5EM1ccPhEZhxkUwCI5ojMGJOsqCtRnZDTlDaMgWRV-ZmcCJCLpuRiRvRDpzN2mOlj1CG5Mfkh0Lv-KQ7PmOjKP2Ok12MweZv7QB909hhyov98XtPlOg7Bmz136RPqhFQHS5c-xvWQfPpCjp3uEn7dzzPy-_rqcXlbrO5v7pa_VoWRVZkLZGbh2tLUbVvzytoWWqhbJ2vhpJGS8wYR2ko2UoIFa2zt3JQZbbWbvmjhjPzYnTs9_e-IKaveJ4NdpwMOY1IcuKwbaGAxod_36Nj2aNVT9L2O_9Wrlgk43wEmDilFdAeEM7W1rrbW1WRdTdYnXLzDjc96ayxH7buPSj93pU3K-g8ebtAxe9PhGwyvlcPKrHVUGOAF4lmfIQ |
| CitedBy_id | crossref_primary_10_1182_blood_2018_08_869057 crossref_primary_10_1016_j_semarthrit_2017_05_004 crossref_primary_10_1007_s12072_023_10637_3 crossref_primary_10_3389_fonc_2021_605296 crossref_primary_10_1111_hepr_12205 crossref_primary_10_1620_tjem_240_277 crossref_primary_10_3748_wjg_v23_i18_3228 crossref_primary_10_1002_jso_24166 crossref_primary_10_1016_j_clinre_2020_06_008 crossref_primary_10_1155_2014_781857 crossref_primary_10_1016_j_cgh_2020_01_018 crossref_primary_10_1002_ygh2_357 crossref_primary_10_3389_fimmu_2023_1277808 crossref_primary_10_1111_tri_12996 crossref_primary_10_1155_2021_9948854 crossref_primary_10_5812_hepatmon_118640 crossref_primary_10_3390_ijms22063113 crossref_primary_10_1111_jgh_14786 crossref_primary_10_1182_blood_2013_05_468694 crossref_primary_10_4103_GJTM_GJTM_33_19 crossref_primary_10_12677_ACM_2023_131072 crossref_primary_10_1016_j_jhepr_2019_10_001 crossref_primary_10_1002_term_2785 crossref_primary_10_1016_j_lfs_2019_05_078 crossref_primary_10_1007_s12325_022_02237_8 crossref_primary_10_1016_j_clinbiochem_2015_07_019 crossref_primary_10_1016_j_cgh_2018_11_047 crossref_primary_10_1182_blood_2016_04_692665 crossref_primary_10_5412_wjsp_v3_i3_29 crossref_primary_10_1016_j_aohep_2020_03_004 crossref_primary_10_1080_17474124_2018_1533813 crossref_primary_10_1111_liv_13093 crossref_primary_10_1002_hep4_1358 crossref_primary_10_3748_wjg_v31_i10_100194 crossref_primary_10_2147_HMER_S244596 crossref_primary_10_1002_hep_30561 crossref_primary_10_1007_s00595_019_01890_x crossref_primary_10_3390_ijms15045412 crossref_primary_10_1111_jgh_13244 |
| ContentType | Journal Article |
| Copyright | 2013 Tohoku University Medical Press |
| Copyright_xml | – notice: 2013 Tohoku University Medical Press |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1620/tjem.229.213 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1349-3329 |
| EndPage | 220 |
| ExternalDocumentID | 23459612 10_1620_tjem_229_213 article_tjem_229_3_229_213_article_char_en |
| Genre | Clinical Trial Journal Article |
| GroupedDBID | --- -~X .55 .GJ 123 29Q 2WC 36B 3O- 53G 5RE 7.U ABCQX ACGFO ADBBV AEGXH AENEX AIAGR ALMA_UNASSIGNED_HOLDINGS BAWUL CS3 DIK DU5 E3Z EBD EMB EMOBN F5P GX1 JSF JSH KQ8 L7B MK0 OK1 OVT P2P RJT RNS RZJ SV3 TKC TR2 W2D WH7 X7J X7M XSB ZGI ZXP AAYXX CITATION CGR CUY CVF ECM EIF M~E NPM 7X8 |
| ID | FETCH-LOGICAL-c476t-e0c5fb6c8bb817ddb3b38bf482f4c44119ee3b749443d3dcd8ff19ecadaf872d3 |
| ISSN | 0040-8727 1349-3329 |
| IngestDate | Thu Jul 10 22:11:04 EDT 2025 Thu May 23 23:49:10 EDT 2024 Tue Jul 01 01:28:53 EDT 2025 Thu Apr 24 23:07:26 EDT 2025 Wed Sep 03 06:05:47 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c476t-e0c5fb6c8bb817ddb3b38bf482f4c44119ee3b749443d3dcd8ff19ecadaf872d3 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
| OpenAccessLink | https://www.jstage.jst.go.jp/article/tjem/229/3/229_213/_article/-char/en |
| PMID | 23459612 |
| PQID | 1314893935 |
| PQPubID | 23479 |
| PageCount | 8 |
| ParticipantIDs | proquest_miscellaneous_1314893935 pubmed_primary_23459612 crossref_primary_10_1620_tjem_229_213 crossref_citationtrail_10_1620_tjem_229_213 jstage_primary_article_tjem_229_3_229_213_article_char_en |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2013-03-01 |
| PublicationDateYYYYMMDD | 2013-03-01 |
| PublicationDate_xml | – month: 03 year: 2013 text: 2013-03-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Japan |
| PublicationPlace_xml | – name: Japan |
| PublicationTitle | The Tohoku Journal of Experimental Medicine |
| PublicationTitleAlternate | Tohoku J. Exp. Med. |
| PublicationYear | 2013 |
| Publisher | Tohoku University Medical Press |
| Publisher_xml | – name: Tohoku University Medical Press |
| References | Mueller, A.R., Platz, K.P. & Kremer, B. (2004) Early postoperative complications following liver transplantation. Best. Pract. Res. Clin. Gastroenterol., 18, 881-900. Endo, Y. & Nakamura, M. (1993) Active translocation of platelets into sinusoidal and Disse spaces in the liver in response to lipopolysaccharides, interleukin-1 and tumor necrosis factor. Gen. Pharmacol., 24, 1039-1053. Adinolfi, L.E., Giordano, M.G., Andreana, A., Tripodi, M.F., Utili, R., Cesaro, G., Ragone, E., Durante Mangoni, E. & Ruggiero, G. (2001) Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis. Br. J. Haematol., 113, 590-595. Takahashi, K., Kozuma, Y., Suzuki, H., Tamura, T., Maruyama, T., Fukunaga, K., Murata, S. & Ohkohchi, N. (2012) Human platelets promote liver regeneration with Kupffer cells in SCID mice. J. Surg. Res., Epub ahead of print. Stroncek, D.F. & Rebulla, P. (2007) Platelet transfusions. Lancet, 370, 427-438. The Trial to Reduce Alloimmunization to Platelets Study Group (1997) Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N. Engl. J. Med., 337, 1861-1869. Myronovych, A., Murata, S., Chiba, M., Matsuo, R., Ikeda, O., Watanabe, M., Hisakura, K., Nakano, Y., Kohno, K., Kawasaki, T., Hashimoto, I., Shibasaki, Y., Yasue, H. & Ohkohchi, N. (2008) Role of platelets on liver regeneration after 90% hepatectomy in mice. J. Hepatol., 49, 363-372. Klingemann, H.G., Self, S., Banaji, M., Deeg, H.J., Doney, K., Slichter, S.J., Thomas, E.D. & Storb, R. (1987) Refractoriness to random donor platelet transfusions in patients with aplastic anaemia: a multivariate analysis of data from 264 cases. J. Haematol., 66, 115-121. Legler, T.J., Fischer, I., Dittmann, J., Simson, G., Lynen, R., Humpe, A., Riggert, J., Schleyer, E., Kern, W., Hiddemann, W. & Kohler, M. (1997) Frequency and causes of refractoriness in multiply transfused patients. Ann. Hematol., 74, 185-189. Murata, K., Shiraki, K., Takase, K., Nakano, T. & Tameda, Y. (1996) Long term follow-up for patients with liver cirrhosis after partial splenic embolization. Hepatogastroenterology, 43, 1212-1217. Anitua, E., Andia, I., Ardanza, B., Nurden, P. & Nurden, A.T. (2004) Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb. Haemost., 91, 4-15. Kawasaki, T., Murata, S., Takahashi, K., Nozaki, R., Ohshiro, Y., Ikeda, N., Pak, S., Myronovych, A., Hisakura, K., Fukunaga, K., Oda, T., Sasaki, R. & Ohkohchi, N. (2010) Activation of human liver sinusoidal endothelial cell by human platelets induces hepatocyte proliferation. J. Hepatol., 53, 648-654. Murata, S., Hashimoto, I., Nakano, Y., Myronovych, A., Watanabe, M. & Ohkohchi, N. (2008b) Single administration of thrombopoietin prevents progression of liver fibrosis and promotes liver regeneration after partial hepatectomy in cirrhotic rats. Ann. Surg., 248, 821-828. Endo, Y. & Nakamura, M. (1992) The effect of lipopolysaccharide, interleukin-1 and tumour necrosis factor on the hepatic accumulation of 5-hydroxytryptamine and platelets in the mouse. Br. J. Pharmacol., 105, 613-619. Merion, R.M., Schaubel, D.E., Dykstra, D.M., Freeman, R.B., Port, F.K. & Wolfe, R.A. (2005) The survival benefit of liver transplantation. Am. J. Transplant., 5, 307-313. Porrett, P.M., Hsu, J. & Shaked, A. (2009) Late surgical complications following liver transplantation. Liver Transpl., 15 Suppl 2, S12-18. Watanabe, M., Murata, S., Hashimoto, I., Nakano, Y., Ikeda, O., Aoyagi, Y., Matsuo, R., Fukunaga, K., Yasue, H. & Ohkohchi, N. (2009) Platelets contribute to the reduction of liver fibrosis in mice. J. Gastroenterol. Hepatol., 24, 78-89. Bashour, F.N., Teran, J.C. & Mullen, K.D. (2000) Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease. Am. J. Gastroenterol., 95, 2936-2939. Nakamura, T., Teramoto, H. & Ichihara, A. (1986) Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc. Natl. Acad. Sci. USA, 83, 6489-6493. Taylor, M.C., Greig, P.D., Detsky, A.S., McLeod, R.S., Abdoh, A. & Krahn, M.D. (2002) Factors associated with the high cost of liver transplantation in adults. Can. J. Surg., 45, 425-434. Daly, P.A., Schiffer, C.A., Aisner, J. & Wiernik, P.H. (1980) Platelet transfusion therapy. One-hour posttransfusion increments are valuable in predicting the need for HLA-matched preparations. JAMA, 243, 435-438. Murata, K., Ito, K., Yoneda, K., Shiraki, K., Sakurai, H. & Ito, M. (2008a) Splenectomy improves liver function in patients with liver cirrhosis. Hepatogastroenterology, 55, 1407-1411. Afdhal, N., McHutchison, J., Brown, R., Jacobson, I., Manns, M., Poordad, F., Weksler, B. & Esteban, R. (2008) Thrombocytopenia associated with chronic liver disease. J. Hepatol., 48, 1000-1007. Diegelmann, R.F. & Evans, M.C. (2004) Wound healing: an overview of acute, fibrotic and delayed healing. Front. Biosci., 9, 283-289. Neuberger, J. & James, O. (1999) Guidelines for selection of patients for liver transplantation in the era of donor-organ shortage. Lancet, 354, 1636-1639. Miyazono, K. & Takaku, F. (1989) Platelet-derived growth factors. Blood. Rev., 3, 269-276. D'Amico, G., Garcia-Tsao, G. & Pagliaro, L. (2006) Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J. Hepatol., 44, 217-231. Seeff, L.B., Everson, G.T., Morgan, T.R., Curto, T.M., Lee, W.M., Ghany, M.G., Shiffman, M.L., Fontana, R.J., Di Bisceglie, A.M., Bonkovsky, H.L. & Dienstag, J.L. (2010) Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin. Gastroenterol. Hepatol., 8, 877-883. Friedman, S.L. (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology, 134, 1655-1669. Matsuo, R., Ohkohchi, N., Murata, S., Ikeda, O., Nakano, Y., Watanabe, M., Hisakura, K., Myronovych, A., Kubota, T., Narimatsu, H. & Ozaki, M. (2008) Platelets strongly induce hepatocyte proliferation with IGF-1 and HGF in vitro. J. Surg. Res., 145, 279-286. Ikeda, N., Murata, S., Maruyama, T., Tamura, T., Nozaki, R., Kawasaki, T., Fukunaga, K., Oda, T., Sasaki, R., Homma, M. & Ohkohchi, N. (2011) Platelet-derived adenosine 5'-triphosphate suppresses activation of human hepatic stellate cell: in vitro study. Hepatol. Res., 42, 91-102. McHutchison, J.G., Dusheiko, G., Shiffman, M.L., Rodriguez-Torres, M., Sigal, S., Bourliere, M., Berg, T., Gordon, S.C., Campbell, F.M., Theodore, D., Blackman, N., Jenkins, J. & Afdhal, N.H. (2007) Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C. N. Engl. J. Med., 357, 2227-2236. Ohta, M., Nishizaki, T., Matsumoto, T., Shimabukuro, R., Sasaki, A., Shibata, K., Matsusaka, T. & Kitano, S. (2005) Analysis of risk factors for massive intraoperative bleeding during laparoscopic splenectomy. J. Hepatobiliary Pancreat. Surg., 12, 433-437. Castera, L., Forns, X. & Alberti, A. (2008) Non-invasive evaluation of liver fibrosis using transient elastography. J. Hepatol., 48, 835-847. Kurata, Y., Shimizu, M., Okazaki, H. & Takemoto, S. (2007) Incidence of Nonhemolytic Transfusion Reaction due to Immnological Reactions. Japanese Journal of Transfusion and Cell Therapy, 53, 43-46. Giannini, E., Borro, P., Botta, F., Fumagalli, A., Malfatti, F., Podesta, E., Romagnoli, P., Testa, E., Chiarbonello, B., Polegato, S., Mamone, M. & Testa, R. (2002) Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis. J. Hepatol., 37, 572-577. Murata, S., Ohkohchi, N., Matsuo, R., Ikeda, O., Myronovych, A. & Hoshi, R. (2007) Platelets promote liver regeneration in early period after hepatectomy in mice. World J. Surg., 31, 808-816. Nakamura, M., Shibazaki, M., Nitta, Y. & Endo, Y. (1998) Translocation of platelets into Disse spaces and their entry into hepatocytes in response to lipopolysaccharides, interleukin-1 and tumour necrosis factor: the role of Kupffer cells. J. Hepatol., 28, 991-999. Patel, A.G., Parker, J.E., Wallwork, B., Kau, K.B., Donaldson, N., Rhodes, M.R., O'Rourke, N., Nathanson, L. & Fielding, G. (2003) Massive splenomegaly is associated with significant morbidity after laparoscopic splenectomy. Ann. Surg., 238, 235-240. Assoian, R.K., Komoriya, A., Meyers, C.A., Miller, D.M. & Sporn, M.B. (1983) Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J. Biol. Chem., 258, 7155-7160. Oka, Y. & Orth, D.N. (1983) Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets. J. Clin. Invest., 72, 249-259. Malik, R., Selden, C. & Hodgson, H. (2002) The role of non-parenchymal cells in liver growth. Semin. Cell. Dev. Biol., 13, 425-431. Heidelbaugh, J.J. & Sherbondy, M. (2006) Cirrhosis and chronic liver failure: part II. Complications and treatment. Am. Fam. Physician, 74, 767-776. |
| References_xml | – reference: Murata, K., Ito, K., Yoneda, K., Shiraki, K., Sakurai, H. & Ito, M. (2008a) Splenectomy improves liver function in patients with liver cirrhosis. Hepatogastroenterology, 55, 1407-1411. – reference: Castera, L., Forns, X. & Alberti, A. (2008) Non-invasive evaluation of liver fibrosis using transient elastography. J. Hepatol., 48, 835-847. – reference: Myronovych, A., Murata, S., Chiba, M., Matsuo, R., Ikeda, O., Watanabe, M., Hisakura, K., Nakano, Y., Kohno, K., Kawasaki, T., Hashimoto, I., Shibasaki, Y., Yasue, H. & Ohkohchi, N. (2008) Role of platelets on liver regeneration after 90% hepatectomy in mice. J. Hepatol., 49, 363-372. – reference: Assoian, R.K., Komoriya, A., Meyers, C.A., Miller, D.M. & Sporn, M.B. (1983) Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J. Biol. Chem., 258, 7155-7160. – reference: Daly, P.A., Schiffer, C.A., Aisner, J. & Wiernik, P.H. (1980) Platelet transfusion therapy. One-hour posttransfusion increments are valuable in predicting the need for HLA-matched preparations. JAMA, 243, 435-438. – reference: D'Amico, G., Garcia-Tsao, G. & Pagliaro, L. (2006) Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J. Hepatol., 44, 217-231. – reference: Endo, Y. & Nakamura, M. (1993) Active translocation of platelets into sinusoidal and Disse spaces in the liver in response to lipopolysaccharides, interleukin-1 and tumor necrosis factor. Gen. Pharmacol., 24, 1039-1053. – reference: Heidelbaugh, J.J. & Sherbondy, M. (2006) Cirrhosis and chronic liver failure: part II. Complications and treatment. Am. Fam. Physician, 74, 767-776. – reference: Matsuo, R., Ohkohchi, N., Murata, S., Ikeda, O., Nakano, Y., Watanabe, M., Hisakura, K., Myronovych, A., Kubota, T., Narimatsu, H. & Ozaki, M. (2008) Platelets strongly induce hepatocyte proliferation with IGF-1 and HGF in vitro. J. Surg. Res., 145, 279-286. – reference: The Trial to Reduce Alloimmunization to Platelets Study Group (1997) Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N. Engl. J. Med., 337, 1861-1869. – reference: Neuberger, J. & James, O. (1999) Guidelines for selection of patients for liver transplantation in the era of donor-organ shortage. Lancet, 354, 1636-1639. – reference: Mueller, A.R., Platz, K.P. & Kremer, B. (2004) Early postoperative complications following liver transplantation. Best. Pract. Res. Clin. Gastroenterol., 18, 881-900. – reference: Miyazono, K. & Takaku, F. (1989) Platelet-derived growth factors. Blood. Rev., 3, 269-276. – reference: Friedman, S.L. (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology, 134, 1655-1669. – reference: Murata, S., Ohkohchi, N., Matsuo, R., Ikeda, O., Myronovych, A. & Hoshi, R. (2007) Platelets promote liver regeneration in early period after hepatectomy in mice. World J. Surg., 31, 808-816. – reference: Endo, Y. & Nakamura, M. (1992) The effect of lipopolysaccharide, interleukin-1 and tumour necrosis factor on the hepatic accumulation of 5-hydroxytryptamine and platelets in the mouse. Br. J. Pharmacol., 105, 613-619. – reference: Patel, A.G., Parker, J.E., Wallwork, B., Kau, K.B., Donaldson, N., Rhodes, M.R., O'Rourke, N., Nathanson, L. & Fielding, G. (2003) Massive splenomegaly is associated with significant morbidity after laparoscopic splenectomy. Ann. Surg., 238, 235-240. – reference: Anitua, E., Andia, I., Ardanza, B., Nurden, P. & Nurden, A.T. (2004) Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb. Haemost., 91, 4-15. – reference: Malik, R., Selden, C. & Hodgson, H. (2002) The role of non-parenchymal cells in liver growth. Semin. Cell. Dev. Biol., 13, 425-431. – reference: Merion, R.M., Schaubel, D.E., Dykstra, D.M., Freeman, R.B., Port, F.K. & Wolfe, R.A. (2005) The survival benefit of liver transplantation. Am. J. Transplant., 5, 307-313. – reference: Afdhal, N., McHutchison, J., Brown, R., Jacobson, I., Manns, M., Poordad, F., Weksler, B. & Esteban, R. (2008) Thrombocytopenia associated with chronic liver disease. J. Hepatol., 48, 1000-1007. – reference: Takahashi, K., Kozuma, Y., Suzuki, H., Tamura, T., Maruyama, T., Fukunaga, K., Murata, S. & Ohkohchi, N. (2012) Human platelets promote liver regeneration with Kupffer cells in SCID mice. J. Surg. Res., Epub ahead of print. – reference: Bashour, F.N., Teran, J.C. & Mullen, K.D. (2000) Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease. Am. J. Gastroenterol., 95, 2936-2939. – reference: Murata, K., Shiraki, K., Takase, K., Nakano, T. & Tameda, Y. (1996) Long term follow-up for patients with liver cirrhosis after partial splenic embolization. Hepatogastroenterology, 43, 1212-1217. – reference: Nakamura, M., Shibazaki, M., Nitta, Y. & Endo, Y. (1998) Translocation of platelets into Disse spaces and their entry into hepatocytes in response to lipopolysaccharides, interleukin-1 and tumour necrosis factor: the role of Kupffer cells. J. Hepatol., 28, 991-999. – reference: Porrett, P.M., Hsu, J. & Shaked, A. (2009) Late surgical complications following liver transplantation. Liver Transpl., 15 Suppl 2, S12-18. – reference: Nakamura, T., Teramoto, H. & Ichihara, A. (1986) Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc. Natl. Acad. Sci. USA, 83, 6489-6493. – reference: Murata, S., Hashimoto, I., Nakano, Y., Myronovych, A., Watanabe, M. & Ohkohchi, N. (2008b) Single administration of thrombopoietin prevents progression of liver fibrosis and promotes liver regeneration after partial hepatectomy in cirrhotic rats. Ann. Surg., 248, 821-828. – reference: Ohta, M., Nishizaki, T., Matsumoto, T., Shimabukuro, R., Sasaki, A., Shibata, K., Matsusaka, T. & Kitano, S. (2005) Analysis of risk factors for massive intraoperative bleeding during laparoscopic splenectomy. J. Hepatobiliary Pancreat. Surg., 12, 433-437. – reference: Adinolfi, L.E., Giordano, M.G., Andreana, A., Tripodi, M.F., Utili, R., Cesaro, G., Ragone, E., Durante Mangoni, E. & Ruggiero, G. (2001) Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis. Br. J. Haematol., 113, 590-595. – reference: Watanabe, M., Murata, S., Hashimoto, I., Nakano, Y., Ikeda, O., Aoyagi, Y., Matsuo, R., Fukunaga, K., Yasue, H. & Ohkohchi, N. (2009) Platelets contribute to the reduction of liver fibrosis in mice. J. Gastroenterol. Hepatol., 24, 78-89. – reference: Kawasaki, T., Murata, S., Takahashi, K., Nozaki, R., Ohshiro, Y., Ikeda, N., Pak, S., Myronovych, A., Hisakura, K., Fukunaga, K., Oda, T., Sasaki, R. & Ohkohchi, N. (2010) Activation of human liver sinusoidal endothelial cell by human platelets induces hepatocyte proliferation. J. Hepatol., 53, 648-654. – reference: Diegelmann, R.F. & Evans, M.C. (2004) Wound healing: an overview of acute, fibrotic and delayed healing. Front. Biosci., 9, 283-289. – reference: Stroncek, D.F. & Rebulla, P. (2007) Platelet transfusions. Lancet, 370, 427-438. – reference: Legler, T.J., Fischer, I., Dittmann, J., Simson, G., Lynen, R., Humpe, A., Riggert, J., Schleyer, E., Kern, W., Hiddemann, W. & Kohler, M. (1997) Frequency and causes of refractoriness in multiply transfused patients. Ann. Hematol., 74, 185-189. – reference: Giannini, E., Borro, P., Botta, F., Fumagalli, A., Malfatti, F., Podesta, E., Romagnoli, P., Testa, E., Chiarbonello, B., Polegato, S., Mamone, M. & Testa, R. (2002) Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis. J. Hepatol., 37, 572-577. – reference: Klingemann, H.G., Self, S., Banaji, M., Deeg, H.J., Doney, K., Slichter, S.J., Thomas, E.D. & Storb, R. (1987) Refractoriness to random donor platelet transfusions in patients with aplastic anaemia: a multivariate analysis of data from 264 cases. J. Haematol., 66, 115-121. – reference: McHutchison, J.G., Dusheiko, G., Shiffman, M.L., Rodriguez-Torres, M., Sigal, S., Bourliere, M., Berg, T., Gordon, S.C., Campbell, F.M., Theodore, D., Blackman, N., Jenkins, J. & Afdhal, N.H. (2007) Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C. N. Engl. J. Med., 357, 2227-2236. – reference: Ikeda, N., Murata, S., Maruyama, T., Tamura, T., Nozaki, R., Kawasaki, T., Fukunaga, K., Oda, T., Sasaki, R., Homma, M. & Ohkohchi, N. (2011) Platelet-derived adenosine 5'-triphosphate suppresses activation of human hepatic stellate cell: in vitro study. Hepatol. Res., 42, 91-102. – reference: Oka, Y. & Orth, D.N. (1983) Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets. J. Clin. Invest., 72, 249-259. – reference: Seeff, L.B., Everson, G.T., Morgan, T.R., Curto, T.M., Lee, W.M., Ghany, M.G., Shiffman, M.L., Fontana, R.J., Di Bisceglie, A.M., Bonkovsky, H.L. & Dienstag, J.L. (2010) Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin. Gastroenterol. Hepatol., 8, 877-883. – reference: Taylor, M.C., Greig, P.D., Detsky, A.S., McLeod, R.S., Abdoh, A. & Krahn, M.D. (2002) Factors associated with the high cost of liver transplantation in adults. Can. J. Surg., 45, 425-434. – reference: Kurata, Y., Shimizu, M., Okazaki, H. & Takemoto, S. (2007) Incidence of Nonhemolytic Transfusion Reaction due to Immnological Reactions. Japanese Journal of Transfusion and Cell Therapy, 53, 43-46. |
| SSID | ssj0034076 |
| Score | 2.1795044 |
| Snippet | Chronic liver disease (CLD), such as hepatitis C, is a progressive disease consisting of the destruction and regeneration of the liver parenchyma, leading to... |
| SourceID | proquest pubmed crossref jstage |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 213 |
| SubjectTerms | Aged Chronic Disease chronic liver disease Female Follow-Up Studies Humans liver cirrhosis Liver Cirrhosis - blood Liver Cirrhosis - physiopathology liver function Liver Function Tests Male Middle Aged Platelet Count platelet transfusion Platelet Transfusion - adverse effects platelet transfusion refractoriness |
| Title | Platelet Transfusion Improves Liver Function in Patients with Chronic Liver Disease and Cirrhosis |
| URI | https://www.jstage.jst.go.jp/article/tjem/229/3/229_213/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/23459612 https://www.proquest.com/docview/1314893935 |
| Volume | 229 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | The Tohoku Journal of Experimental Medicine, 2013, Vol.229(3), pp.213-220 |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKQIgXxDcdHzISPFUpbex8-BGhjQmtA4lU6ltkOw7N1iZTPh62v55zYmcp6qTBS9Tal1N798vlzr47I_SRc0-3DVfOLJEzB_xb5rCZUIBllvqeVJ5oG2kvzvyTJf2-8laj0dUga6mpxVRe760r-R-twhjoVVfJ_oNme6YwAJ9Bv3AFDcP1Tjr-uQFPEQSvD3oA97Op2sTFdplAVZONTrmY6BeXTWg0TVRNRZvs-uIaOrNT09W5ZWW5LqqsGrquUbEuLpphq4md0wH-3qRf8LK54tvWN434hVqD6Rhol3de668ik-us7GeAUteYrbscA37d7E5um9Iy5GmzzYZrFvr8CJu0ZcwsocwhxKx1qD1jxja75ms2jN2NpSV73wC-q1Mm63O1ncLNU0O222j77Ed8vDw9jaOjVXQP3XeDoN3h_7bqs4MIxLltYZr9UaZmArh_HvLe8WYenIND_1vdHqu0Pkv0BD02wQb-0iHnKRqp_Bl6uDCaeo64BRAeAAhbAOEWGNgCCGc5tgDCGkDYAMjQGQBhABDuAfQCLY-Poq8njjlzw5E08GtHzaSXCl-GQoTzIEkEESQUKQ3dlEpwnedMKSICyiglCUlkEqYpjEme8DQM3IS8RAd5kavXCHNGFZBxwXlIPUaYRyRwDlQwp7pl1BhNrOxiaRrS63NRNrEOTEHSsZZ0DJKOQdJj9KmnvuwasdxCxzo19FTm8byhIpa2n9IVjmBQxuiD1VwMVlZvnfFcFU0Vz8lcd2lixBujV51Ke_4ugX8HgcLhHe5-gx7dPA9v0UFdNuodeLW1eN_i7w9GEKz_ |
| linkProvider | Geneva Foundation for Medical Education and Research |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Platelet+transfusion+improves+liver+function+in+patients+with+chronic+liver+disease+and+cirrhosis&rft.jtitle=Tohoku+journal+of+experimental+medicine&rft.au=Maruyama%2C+Takehito&rft.au=Murata%2C+Soichiro&rft.au=Takahashi%2C+Kazuhiro&rft.au=Tamura%2C+Takafumi&rft.date=2013-03-01&rft.issn=1349-3329&rft.eissn=1349-3329&rft.volume=229&rft.issue=3&rft.spage=213&rft_id=info:doi/10.1620%2Ftjem.229.213&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0040-8727&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0040-8727&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0040-8727&client=summon |